US BROKER MOVES: CRWD upgraded at Piper Sandler; OWL downgraded at Barclays

UPGRADES

Aehr Test Systems (AEHR) upgraded from Neutral to Outperform at William Blair
AppLovin (APP) upgraded from Sell to Neutral at Arete; PT USD 340
CrowdStrike (CRWD) upgraded from Neutral to Overweight at Piper Sandler; PT USD 520
Dorman Products (DORM) upgraded from Hold to Buy at Jefferies; PT USD 140
Dutch Bros (BROS) upgraded from Neutral to Buy at Goldman; PT USD 75
First American (FAF) upgraded from Equal-Weight to Overweight at Stephens; PT USD 81
Flywire (FLYW) upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 17
Frontdoor (FTDR) upgraded from Sell to Neutral at Goldman; PT USD 67
Hyster-Yale (HY) upgraded from Market Perform to Outperform at Northland; PT USD 50
JetBlue (JBLU) upgraded from Underweight to Equal-Weight at Barclays
Netflix (NFLX) upgraded from Neutral to Overweight at JPMorgan; PT USD 120
South Plains (SPFI) upgraded from Neutral to Overweight at Piper Sandler; PT USD 48
StepStone (STEP) upgraded from Equal-Weight to Overweight at Barclays; PT USD 55
Twilio (TWLO) upgraded from Hold to Buy at TD Cowen; PT USD 160
Zions (ZION) upgraded from Equal-Weight to Overweight at Morgan Stanley; PT USD 75

DOWNGRADES

Aardvark Therapeutics (AARD) downgraded from Buy to Neutral at H.C. Wainwright
Aardvark Therapeutics (AARD) downgraded from Overweight to Equal-Weight at Morgan Stanley
Aardvark Therapeutics (AARD) downgraded from Outperform to Sector Perform at RBC; PT USD 6
Aardvark Therapeutics (AARD) downgraded from Buy to Hold at Stifel; PT USD 6
Arcellx (ACLX) downgraded from Buy to Hold at TD Cowen
AZZ (AZZ) downgraded from Overweight to Equal-Weight at Wells Fargo; PT USD 132
Blue Owl Capital (OWL) downgraded from Overweight to Equal-Weight at Barclays; PT USD 11
Fiverr (FVRR) downgraded from Buy to Neutral at BTIG
Frontier Airlines (ULCC) downgraded from Equal-Weight to Underweight at Barclays
GitLab (GTLB) downgraded from Buy to Hold at TD Cowen; PT USD 29
Novo (NVO) downgraded from Buy to Neutral at Goldman; PT USD 41
Playtika (PLTK) downgraded from Buy to Neutral at Wedbush; PT USD 3
SITE Centers (SITC) downgraded from Overweight to Neutral at Piper Sandler; PT USD 6.50

INITIATIONS

Bob's Discount Furniture (BOBS) initiated at Outperform at Raymond James
Bob's Discount Furniture (BOBS) initiated at Buy at Loop Capital; PT USD 28
Bob's Discount Furniture (BOBS) initiated at Neutral at Baird; PT USD 22
Bob's Discount Furniture (BOBS) initiated at Overweight at Morgan Stanley
Bob's Discount Furniture (BOBS) initiated at Outperform at RBC; PT USD 26
Bob's Discount Furniture (BOBS) initiated at Overweight at JPMorgan
Bob's Discount Furniture (BOBS) initiated at Neutral at Goldman; PT USD 25
Bob's Discount Furniture (BOBS) initiated at Overweight at KeyBanc; PT USD 28
Bob's Discount Furniture (BOBS) initiated at Buy at UBS; PT USD 27
Didi Global (DIDIY) ADRs initiated at Buy at UOB Kay Hian; PT USD 6.60
Dynatrace (DT) initiated at Neutral at Macquarie; PT USD 36
Eikon Therapeutics (EIKN) initiated at Overweight at Cantor
Eikon Therapeutics (EIKN) initiated at Outperform at Mizuho Securities
Eikon Therapeutics (EIKN) initiated at Overweight at Morgan Stanley
Eikon Therapeutics (EIKN) initiated at Overweight at JPMorgan; PT USD 29
Forgent Power Solutions (FPS) initiated at Outperform at Oppenheimer
Forgent Power Solutions (FPS) initiated at Buy at TD Cowen; PT USD 45
Forgent Power Solutions (FPS) initiated at Equal-Weight at Morgan Stanley
Forgent Power Solutions (FPS) initiated at Overweight at Barclays; PT USD 44
Forgent Power Solutions (FPS) initiated at Overweight at JPMorgan; PT USD 40
Forgent Power Solutions (FPS) initiated at Overweight at KeyBanc; PT USD 41
Forgent Power Solutions (FPS) initiated at Buy at Jefferies; PT USD 44
Forgent Power Solutions (FPS) initiated at Buy at Goldman; PT USD 48
NextTrip (NTRP) initiated at Buy at Ascendiant Capital; PT USD 7
Regentis Biomaterials (RGNT) initiated at Buy at ThinkEquity; PT USD 10
Relmada Therapeutics (RLMD) initiated at Buy at Lucid Capital Markets
VeraDermics (MANE) initiated at Outperform at Leerink; PT USD 75
VeraDermics (MANE) initiated at Buy at Citi; PT USD 85
VeraDermics (MANE) initiated at Buy at Jefferies; PT USD 75
VeraDermics (MANE) initiated at Overweight at Cantor
Versant Media (VSNT) initiated at Hold at TD Cowen; PT USD 32